Stay updated on Paltusotine for Acromegaly Treatment Clinical Trial
Sign up to get notified when there's something new on the Paltusotine for Acromegaly Treatment Clinical Trial page.

Latest updates to the Paltusotine for Acromegaly Treatment Clinical Trial page
- Check4 days agoChange DetectedA site-wide NIH announcement about the website transition and updated AI/SI terminology was added, and the site revision changed from v3.7.1 to v3.7.2. The study page continues to show a 403 error.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe footer now identifies the site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check32 days agoChange DetectedThe study page now shows a 403 Forbidden error. The study record content is inaccessible, though site navigation remains visible.SummaryDifference17%

- Check39 days agoChange DetectedRevision indicator updated from v3.6.6 to v3.7.0 on the page, signaling a non-substantive update to the page template or CMS; no changes to the study data or eligibility criteria are reflected.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page revision was updated from Revision: v3.6.5 to Revision: v3.6.6, indicating a minor internal update. No visible study content or functionality appears to be affected.SummaryDifference0.0%

- Check60 days agoChange DetectedAdds a line '2018 ( U.S. NIH Grant/Contract )' to the study's identifiers, signaling NIH funding for the trial. This provides funding attribution within the study record.SummaryDifference0.0%

Stay in the know with updates to Paltusotine for Acromegaly Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Paltusotine for Acromegaly Treatment Clinical Trial page.